Heart Failure and Heart Transplant Publications

• Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmerak R, Spray TL, Wessel DL.  The efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107:996-1002.
• Hoffman TM, Taeed R, Niles JP, McMillin MA, Perkins LA, Feltes TF.  Parental factors impacting the enrollment of children in cardiac critical care clinical trials.  Pediatr Cardiol 2007;8(3):167-171.
• Astor TL, Galantowicz M, Phillips A, Davis JT, Hoffman TM.  Domino heart transplantation involving infants. Am J Transplant 2007;7:2626-29.
• Hoffman TM, Spray TL, Gaynor JW, Clark BJ, Bridges ND.  Survival after acute graft failure in pediatric thoracic organ transplant recipients.  Pediatric Transplantation 2000; 4(2):112-17.
• Hoffman TM, Gaynor JW, Bridges ND, Paridon S, Spray TL.  Aortic homograft interposition for management of complete tracheal anastomotic disruption after heart-lung transplantation.  J Thorac Cardiovasc Surg 2001;121(3):587-588.
• Hoffman TM, Rhodes LA, Wieand TS, Spray TL, Bridges ND. Arrhythmias after pediatric lung transplantation. Pediatric Transplantation 2001;5(5):349-52.
• Hoffman TM, Wernovsky G, Atz AM, Bailey JM, Akbary A, Nelson DP, Chang AC, Kulik TJ, Spray TL, Wessel DL.  Trial Designs: Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP study). Am Heart J 2002;143(1):15-21.
• Fleenor JT, Hoffman TM, Bush DM, Paridon SM, Clark BJ, Spray TL, Bridges ND.  Pneumatosis intestinalis after pediatric thoracic organ transplant. Pediatrics 2002;109(5):e78-8.
• Wernovsky G, Hoffman TM.  Pediatric heart failure management: Solving the puzzle. Critical Care Med 2001;29(10 Suppl):212-3.
• Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC, Kulik T, Spray TL, Akbary A, Miller RP, Wernovsky G.  A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. Journal of Pharmacokinetics and Pharmacodynamics 2004 Feb;31(1):43-59.
• Morris MC, Ittenbach RF, Godinez RI, Portnoy JD, Tabbutt S, Hanna BD, Hoffman TM, Gaynor JW, Connelly JT, Helfaer MA, Spray TL, Wernovsky G.  Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with ECMO. Crit Care Med 2004 Apr;32(4):1061-1069.
• Cua CL, Hoffman TM, Taeed R, Weinstein S, Gomez D, Olshove VF, Craenen J. Cerebral saturations trend with mixed venous saturations in patients undergoing extracorporeal life support. Perfusion 2004;19:171-176.
• Zuppa AF, Nicolson SC, Adamson PC, Wernovsky G, Mondick J, Burnham N, Hoffman TM, Gaynor JW, Davis LA, Greeley WJ, Spray TL, Barrett J. The impact of cardiopulmonary bypass and modified ultrafiltration on the plasma population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing Stage 1 reconstruction. Anesth Analg 2006;102(4):1062-9.
• Luce WA, Hoffman TM, Bauer JA. Bench to Bedside review:  Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis. Critical Care 2007;11:228-237.
• Garg R, Raman SV, Hoffman TM, Hayes J, Daniels CJ.  Serum markers of systemic right ventricular function and exercise performance.  Pediatr Cardiol 2008 May;29(3):641-648.
• Dyke PC 2nd, Konczal L, Bartholomew D, McBride KL, Hoffman TM.  Acute dilated cardiomyopathy in a patient with deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase.  Pediatr Cardiol (in press).
• Kirk R, Naftel D, Hoffman TM, Almond C, Boyle G, Caldwell RL, Kirklin JK, White K, Dipchand AI.  Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: A Multi-Institutional study. (submitted)
• Hoffman TM, Spray TL. Transplantation for Hypoplastic Left Heart Syndrome. Hypoplastic Left Heart Syndrome, Hennein HA and Bove EL (eds), Chapter 18, Futura Publishing, Armonk, NY 2002;289-300.
• Hoffman TM, Spray TL. Infant Heart Transplantation. Hypoplastic Left Heart Syndrome, Rychik J and Wernovsky G (eds), Kluwer Academic Publishers, Norwell, MA 2003; 241-250.
• Luce WA, Joshi MS, Hoffman TM, Feltes TF, Bauer JA.  Immune mechanisms in pediatric cardiovascular disease. Immune Dysfunction and Immunotherapy in Heart Disease, edited by Ronald R. Watson and Douglas F. Larson, Chapter 2, 2007; 6-16.
• Olson TM, Hoffman TM, Chan DP.  Dilated cardiomyopathy.  Moss and Adams’ Heart Disease in Infants, Children, and Adolescents, edited by Allen HD, Driscoll DJ, Shaddy RE, and Feltes TF. Lippincott Williams and Wilkins, Philadelphia 2008; 1195-1206.
• Allen HD, Mendell JR, Hoffman TM.  The heart in muscular dystrophies. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents, edited by Allen HD, Driscoll DJ, Shaddy RE, and Feltes TF. Lippincott Williams and Wilkins, Philadelphia 2008; 1234-1241.